These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22853758)

  • 1. The sweet side of tumor immunotherapy.
    Freire T; Osinaga E
    Immunotherapy; 2012 Jul; 4(7):719-34. PubMed ID: 22853758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional mimicry of tumor-associated antigens by antiidiotypic antibodies.
    Herlyn D; Wettendorff M; Iliopoulos D; Koprowski H
    Exp Clin Immunogenet; 1988; 5(4):165-75. PubMed ID: 3078570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble low-molecular-mass heat shock proteins and tumor-associated antigens in prevention and therapy of chemically-induced cancers.
    Zusman I; Kossoy G; Ben-Hur H
    In Vivo; 2001; 15(6):529-34. PubMed ID: 11887340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?
    Reilly RT; Emens LA; Jaffee EM
    Curr Opin Investig Drugs; 2001 Jan; 2(1):133-5. PubMed ID: 11527005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.
    Pashov A; Monzavi-Karbassi B; Kieber-Emmons T
    Vaccine; 2009 May; 27(25-26):3405-15. PubMed ID: 19200843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody.
    Zhou P; Qiu J; L'Italien L; Gu D; Hodges D; Chao CC; Schebye XM
    J Immunother; 2010 Oct; 33(8):789-97. PubMed ID: 20842058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
    Sundstedt A; Celander M; Ohman MW; Forsberg G; Hedlund G
    Int Immunopharmacol; 2009 Aug; 9(9):1063-70. PubMed ID: 19410661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options].
    Stremmel C; Klein P; Hohenberger W
    Chirurg; 2002 Mar; 73(3):255-61. PubMed ID: 11963500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 15 as a promising candidate for tumor immunotherapy.
    Jakobisiak M; Golab J; Lasek W
    Cytokine Growth Factor Rev; 2011 Apr; 22(2):99-108. PubMed ID: 21531164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.
    Khalil DN; Budhu S; Gasmi B; Zappasodi R; Hirschhorn-Cymerman D; Plitt T; De Henau O; Zamarin D; Holmgaard RB; Murphy JT; Wolchok JD; Merghoub T
    Adv Cancer Res; 2015; 128():1-68. PubMed ID: 26216629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
    Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
    Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in carbohydrate-based cancer vaccines.
    Jin KT; Lan HR; Chen XY; Wang SB; Ying XJ; Lin Y; Mou XZ
    Biotechnol Lett; 2019 Jul; 41(6-7):641-650. PubMed ID: 30993481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.